Curaleaf Holdings Inc

Change company Symbol lookup

Select an option...

CURLF Curaleaf Holdings Inc

BRCC BRC Inc

FSMAX Fidelity® Extended Market Index Fund

PFE Pfizer Inc

DUNE Dune Acquisition Corp

METV Roundhill Ball Metaverse ETF

TBNK Territorial Bancorp Inc

BAC Bank of America Corp

ICD Independence Contract Drilling Inc

NOK Nokia Oyj

Go

By Steve Gelsi Curaleaf sees traction in N.J., Ill., Fla., and looks toward growth in NY, Conn., and overseas Curaleaf Holdings Inc. remains on track to generate up to $1.5 billion in revenue in 2022 -- up from $1.2 billion in 2021...(MarketWatch)

New Jersey'a Cannabis Regulatory Commission on Monday OK'd applications from seven cannabis companies to sell cannabis to adults over 21, pending operational inspections and issuance of new licenses. Acreage Holdings , Ascend Wellness Holdings...(MarketWatch)

By Steve Gelsi NJ is blowing past deadlines for its adult-use program as regulators seek to ensure there'll be ample supply New Jersey may be known as the Garden State, but its adult use cannabis market continues to take longer than...(MarketWatch)

By Steve Gelsi Cresco Labs is buying Columbia Care for $2.1 billion in stock in a deal that will help expand its U.S. footprint Cresco Labs Inc. CEO Charlie Bachtell said his company's $2 billion all-stock purchase of Columbia Care...(MarketWatch)

By Steve Gelsi CEO Joe Bayen expects 2022 to be 'a good year' for company and the cannabis industry Curaleaf Holdings Inc. reported a narrower fourth-quarter loss that was wider than Wall Street estimates, but the cannabis company...(MarketWatch)

(END) Dow Jones Newswires March 04, 2022 07:49 ET (12:49 GMT) (MarketWatch)

By Steve Gelsi Cannabis company says rumors about its founder and executive chairman and another shareholder are 'incorrect' U.S. cannabis company Curaleaf has told investors that it is not subject to any sanctions against Russia...(MarketWatch)

(END) Dow Jones Newswires February 25, 2022 06:22 ET (11:22 GMT) (MarketWatch)

By Barbara Kollmeyer Critical information for the U.S. trading day Investors are still trying to come to grips with that double whammy of nosebleed consumer prices and 100-basis-point increase talk from St. Louis Federal Reserve...(MarketWatch)

By Steve Gelsi Tilray grows its top line even as it faces a potential loss in the quarter Tilray Inc. will likely grow its sales over the previous quarter but it's expected to post a net loss when it becomes the first major cannabis...(MarketWatch)

By Steve Gelsi Village co-founder Dan Pettrigrew is helping steer the company toward growth in New York and other states coming on line with adult-use licenses With states such as New York planning to issue social equity cannabis...(MarketWatch)

By Steve Gelsi Big federal moves on cannabis remain unlikely in 2022 even as more states go legal Cannabis companies look toward 2022 with plans to expand their businesses to legal markets in more states despite an expected lack of...(MarketWatch)

Alliance Global Securities analyst Aaron Grey said Tuesday a $425 million debt deal by Curaleaf Holdings Inc. will result in cost savings of about $20 million from lower interest payments. Grey reiterated a buy rating on Curaleaf and said...(MarketWatch)